Notes on some recent antibiotic literature. II. The new antibiotics.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002228:Carbenicillin / Q000009:adverse effects / Q000627:therapeutic use; D002512:Cephalothin / Q000009:adverse effects / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D003428:Cross Infection; D004318:Doxycycline / Q000009:adverse effects / Q000627:therapeutic use; D004338:Drug Combinations; D005839:Gentamicins / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007231:Infant, Newborn; D007239:Infections / Q000188:drug therapy*; D008034:Lincomycin / Q000009:adverse effects / Q000627:therapeutic use; D008875:Middle Aged; D009761:Nystatin / Q000627:therapeutic use; D010403:Penicillin Resistance; D012293:Rifampin / Q000627:therapeutic use; D013203:Staphylococcal Infections / Q000188:drug therapy; D013752:Tetracycline / Q000009:adverse effects / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D004338:Drug Combinations; D005839:Gentamicins; D009761:Nystatin; D008034:Lincomycin; D013752:Tetracycline; D002228:Carbenicillin; D004318:Doxycycline; D002512:Cephalothin; D012293:Rifampin